HQL

abrdn Life Sciences Investors
HQL

Overview Fund Activity

41 hedge funds and large institutions have $47.6M invested in abrdn Life Sciences Investors in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 11 closing their positions.

Holders
41
Holders Change
-8
Holders Change %
-16.33%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
17
Reduced
13
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NIM
1
Needham Investment Management
New York
$11.2M
2
RJA
2
Raymond James & Associates
Florida
$1.85M
3
Cohen & Steers
3
Cohen & Steers
New York
$1.16M
4
LPL Financial
4
LPL Financial
California
$2.35M
5
FHA
5
Flagship Harbor Advisors
Massachusetts
$3.44M

Top Sellers

1
First Trust Advisors
1
First Trust Advisors
Illinois
$0
2
Citigroup
2
Citigroup
New York
$1.85M
3
AGM
3
Alpine Global Management
New York
$0
4
DA
4
Doliver Advisors
Texas
$0
5
Stifel Financial
5
Stifel Financial
Missouri
$506K
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
– – -4 Closed
JWA
52
JFS Wealth Advisors
Pennsylvania
$0 3 – –
GAM
53
Gemmer Asset Management
California
$0 19 +19 New
1 2
3